Nov 20 2026 This Week in Cardiology
The failures of ZEUS, HORIZON, and CorCal; numerous papers from the JACC special issue on LAAC; and the COAST-AF trial in JAMA are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Failure of ZEUS/HORIZON at AHA and CorCal at ESC Three Lessons From the 'Negative' ZEUS and HORIZON Trials of IL-6- and Lp(a)-Lowering Drugs https://www.medscape.com/viewarticle/three-lessons-negative-zeus-and-horizon-trials-il-6-and-lp-2026a10015vj ZEUS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2612126 HORIZON Trial https://www.nejm.org/doi/10.1056/NEJMoa2610159 TARGET-CTCA Trial https://www.nejm.org/doi/10.1056/NEJMoa2608903 CorCal Press Release https://www.escardio.org/news/press/press-releases/new-data-presented-on-the-use-of-coronary-artery-calcium-for-cardiovascular-risk-assessment/ II LAAC Evidence ASAP-TOO Trial 10.1016/j.jacc.2026.10.007 Regulatory History of Watchman LAAC Device 10.1016/j.jacc.2026.08.044 III More Papers from the JACC Special Issue on LAAC Insurer Coverage of Percutaneous LAAO 10.1016/j.jacc.2026.07.038 LAAO in the United States, 2016-2025: Utilization, Patient Selection, and Acute Outcomes 10.1016/j.jacc.2026.09.022 LAAC for AF: Overhyped Device or Reasonable Alternative to OAC? 10.1016/j.jacc.2026.05.017 IV COAST-AF – A Breakthrough in AF Ablation or More Noise? COAST-AF Trial https://jamanetwork.com/journals/jama/fullarticle/2856404 STAR AF II Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1408288 The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact [email protected] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
